MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > Any thoughts on how close they are to this statement

<< Previous

Bullboard Posts

Next >>

Post by D69recceon Jan 17, 2021 6:29pm

203 Views

Post# 32316347

Any thoughts on how close they are to this statement

From the last NR

"This shall enable us to introduce the new product version and address the additional market demands, focussing our attention on the production of 50,000 units of REVEALCOVID-19™ PLUS Total Antibody Test daily.

Saw a few posts with folks interpreting this as 50,000 tests monthly. It states 50,000 tests daily in the NR. That's quite staggering if they are close to making that many a day.

Any thoughts?

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features